Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 188 participants.
Also called NCT02496000
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 188 participants
- Sponsor
- Registry
-
NCT02496000
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02496000. Randomized; quadruple masking; primary purpose treatment. Start 2015-07-27 (actual); primary completion 2016-06-27 (actual). Results posted on 2017-02-17.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
- Condition
- Diabetes Type 2
- Intervention (Drug)
- ORMD-0801
- Intervention (Drug)
- Placebo Comparator
- Lead sponsor
- Oramed, Ltd.
- Collaborator
- Integrium
Record details
- Record id
cardio:ct-nct02496000- Content hash
a12b778a3b1a340f1d687875719d91d0c1442bbb4cae04a99f7ecaf8400b0a0a